2012-02-03 18:31:00 - ImClone Systems Incorporated: Company Profile and SWOT Analysis - a new company profile report on companiesandmarkets.com

ImClone Systems Incorporated (ImClone) is a biopharmaceutical company engaged in research and development and commercialisation of oncology methodologies and therapies. The company is principally focused on growth factor blockers and angiogenesis inhibitors for treating a variety of cancers. Erbitux, a type of therapeutic monoclonal antibody is the trademark product of ImClone. The company has granted Merck KgaA, the exclusive rights to develop and commercialize ERBITUX outside of the US and Canada as well as co-exclusive rights to develop in Japan. Further, the company´s product pipeline has several molecules in mid- to late clinical development stages targeting a wide range of major solid tumor types. In addition it has several investigational monoclonal antibodies in various clinical development stages. Imclone was acquired

 

 

by Eli Lilly and Company in 2008, and it became a wholly owned subsidiary of Eli Lilly. The company operates in the US and internationally in Europe. ImClone is headquartered in New York, the US.

Synopsis

The ´ImClone Systems Incorporated: Company Profile and SWOT Analysis´ contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Scope

• Examines and identifies key information and issues about ´ImClone Systems Incorporated´ for business intelligence requirements
• Studies and presents the company´s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
• The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries

Reasons To Buy

• Quickly enhance your understanding of the company
• Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
• Increase business/sales activities by understanding your competitors´ businesses better
• Recognize potential partnerships and suppliers

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company+Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.